Enzymotec Launches its Version of Krill Oil
This announcement follows previous announcements made through 2006 regarding the expansion of its production facility and R&D investments and the diversification of its product line within wider range of high quality of phospholipids.
13/02/07 Enzymotec had announced it can produce in high capacity its own krill oil version, which surpasses currently available brands in its quality.
This announcement follows previous announcements made through 2006 regarding the expansion of its production facility and R&D investments and the diversification of its product line within wider range of high quality of phospholipids.
"This product is yet another expansion of our proprietary line of structured phospholipids. These products, provide additional health benefits resulting from their unique metabolic faith" says Enzymotec CEO, Dr. Ariel Katz.
"Krill oil market is currently dominated by the NKO brand, which offers a phosphlipid-omega-3 combination .I am glad to say that our control over raw materials, unique bio-processing technologies and know-how enabled us to outperform current line of products in all matters concerning composition, service and cost effectiveness", concludes Dr. Katz.
